This includes ophthalmic drugs injected or used in conjunction with eye surgery and cardioplegic solutions. Patients should contact their healthcare provider if they experience symptoms of meningitis.
At this time, no cases of infection have been reported in connection with any NECC-produced ophthalmic drug, but the FDA believes the class of products could present similar infection risks.
